SC
MDGL icon

SouthState Corp’s Madrigal Pharmaceuticals MDGL Stock Holding History

SouthState Corp’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07K Hold
2
– – ﹤0.01% 1099
2026
Q1 		$1.05K Hold
2
– – ﹤0.01% 1038
2025
Q4 		$1.17K Hold
2
– – ﹤0.01% 1090
2025
Q3 		$918 Hold
2
– – ﹤0.01% 1086
2025
Q2 		$606 Sell
2
-2
-50% -$596 ﹤0.01% 1391
2025
Q1 		$1.32K Buy
+4
New +$1.31K ﹤0.01% 1273

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SouthState Corp's MDGL Position: Q2 2026 in Review

SouthState Corp held its Madrigal Pharmaceuticals (MDGL) position steady in Q2 2026 at 2 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

SouthState Corp first reported a position in MDGL in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.32K in Q1 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • SouthState Corp held 2 shares of Madrigal Pharmaceuticals worth $1.07K as of Q2 2026.
  • SouthState Corp left its Madrigal Pharmaceuticals share count unchanged in Q2 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #1099 holding.
  • SouthState Corp first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • SouthState Corp's Madrigal Pharmaceuticals position peaked at $1.32K in Q1 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.